FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular to gynecology, and is intended to prevent menstrual disorder in patients. Level of vitamin D in the blood serum is determined. With its content < 16.2 ng/ml, DNA isolation and genotyping of genes are performed GC rs2282679, CYP2R1 rs2060793, VDR rs2228570. When genotypes are identified C/C VDR rs2228570 and/or A/C GC rs2282679 vitamin D at a dose of 4,000 U/day is prescribed. When genotypes are identified T/T VDR rs2228570, T/T CYP2R1 rs2060793 and A/A GC rs2282679 2,000 U/day for 9 months is prescribed.
EFFECT: invention provides a differential choice of the optimal dose of vitamin D.
1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING PREECLAMPSIA IN PATIENTS WITH AN AGGRAVATED OBSTETRIC ANAMNESIS | 2016 |
|
RU2663593C2 |
| METHOD FOR PREVENTION OF PREECLAMPSIA IN CARRIERS OF F2G20210A MUTATION WITH SUPERTHRESHOLD INCREASE OF PROTHROMBIN ACTIVITY | 2019 |
|
RU2712444C1 |
| METHOD FOR PREDICTION OF MENSTRUAL RECOVERY IN PATIENTS WITH PUBERTAL UTERINE BLEEDINGS | 2011 |
|
RU2477858C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR SPECIFIC EATING DISORDER IN PATIENTS WITH SECONDARY OLIGOMENORRHEA | 2007 |
|
RU2386139C2 |
| METHOD FOR PREDICTION OF RISK OF GENITAL PROLAPSE IN WOMEN | 2023 |
|
RU2823209C1 |
| METHOD FOR TREATMENT OF POLYCYSTIC OVARY SYNDROME | 2017 |
|
RU2665969C1 |
| METHOD OF TREATING DIFFUSE BENIGN BREAST DYSPLASIA | 2018 |
|
RU2702010C1 |
| METHOD OF CREATING A PERSONALIZED PROGRAM OF PREGRAVIDARY PREPARATION OF PATIENTS WITH INFERTILITY AND OBESITY FOR AUXILIARY REPRODUCTIVE TECHNOLOGIES | 2022 |
|
RU2796893C1 |
| METHOD FOR PREDICTING A DECREASE IN OVARIAN RESERVE IN PATIENTS OF REPRODUCTIVE AGE AFTER SURGICAL TREATMENT OF DEEP INFILTRATIVE ENDOMETRIOSIS | 2022 |
|
RU2775543C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING DEEP INFILTRATIVE ENDOMETRIOSIS IN WOMEN OF REPRODUCTIVE AGE | 2022 |
|
RU2775544C1 |
